114 Publications (Page 5 of 5)
1995
The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
Grell, MatthiasDouni, EleniWajant, HaraldLöhden, MatthiasClauss, MatthiasMaxeiner, BeateGeorgopoulos, SpirosLesslauer, WernerKollias, GeorgePfizenmaier, Klaus and Scheurich, Peter
Cell, vol. 83, (no. 5), pp. 802, 1995. | Journal Article
1994
A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response.
Kao, JFan, Y GHaehnel, IBrett, JGreenberg, SClauss, Matthias AKayton, MHouck, KKisiel, W and Seljelid, R
The Journal of biological chemistry, vol. 269, (no. 13), pp. 9774-82, 1994/Apr/1. | Journal Article
1993
Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.
Shen, HClauss, Matthias ARyan, JSchmidt, A MTijburg, PBorden, LConnolly, DStern, David B and Kao, J
Blood, vol. 81, (no. 10), pp. 2767-73, 1993/May/15. | Journal Article
 
Endothelial-monocyte activating polypeptides (EMAPs): tumor derived mediators which activate the host inflammatory response.
Kao, JFan, Y GHaehnel, IClauss, Matthias A and Stern, David B
Behring Institute Mitteilungen, (no. 92), pp. 92-106, 1993/Aug. | Journal Article
1992
Endothelial monocyte-activating polypeptide II: A novel tumor-derived polypeptide that activates host-response mechanisms.
Kao, J.Ryan, J.Brett, G.Chen, JingxianShen, HongFan, Yan-GGodman, G.Familletti, PCClauss, Matthias A and al., et
Journal of Biological Chemistry, vol. 267, (no. 28), pp. 20239-20247, 1992. | Journal Article
 
Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.
Schmidt, A MVianna, MGerlach, MBrett, JRyan, JKao, JEsposito, CHegarty, HHurley, W and Clauss, Matthias A
The Journal of biological chemistry, vol. 267, (no. 21), pp. 14987-97, 1992/Jul/25. | Journal Article
1991
Hypoxia induces endothelial cell synthesis of membrane-associated proteins.
Ogawa, SClauss, Matthias AKuwabara, KShreeniwas, RButura, CKoga, S and Stern, David B
Proceedings of the National Academy of Sciences of the United States of America, vol. 88, (no. 21), pp. 9897-901, 1991/Nov/1. | Journal Article
 
Selective induction of endothelial cell tissue factor in the presence of a tumour-derived mediator: a potential mechanism of flavone acetic acid action in tumour vasculature.
Murray, Jeffrey CClauss, Matthias ADenekamp, J and Stern, David B
International journal of cancer. Journal international du cancer, vol. 49, (no. 2), pp. 254-9, 1991/Sep/9. | Journal Article
 
Tumour-derived factors which induce endothelial tissue factor and enhance the procoagulant response to TNF.
Murray, Jeffrey CClauss, Matthias AThurston, G and Stern, David B
International journal of radiation biology, vol. 60, (no. 1-2), pp. 273-7, 1991 Jul-Aug. | Journal Article
1990
A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin.
Clauss, Matthias AMurray, Jeffrey CVianna, Mde Waal, RThurston, GNawroth, PGerlach, HBach, RFamilletti, P C and Stern, David B
The Journal of biological chemistry, vol. 265, (no. 12), pp. 7078-83, 1990/Apr/25. | Journal Article
 
Epidermal G1‐chalone and transforming growth factor‐β are two different endogenous inhibitors of epidermal cell proliferation
Richter, K. HartmutSchnapke, RubenClauss, MatthiasFürstenberger, GerhardHinz, Detlef and Marks, Friedrich
Journal of Cellular Physiology, vol. 142, (no. 3), pp. 504, March 1990. | Journal Article
 
The effect of hypoxia on capillary endothelial cell function: modulation of barrier and coagulant function.
Ogawa, SShreeniwas, RBrett, JClauss, Matthias AFurie, M and Stern, David M
British journal of haematology, vol. 75, (no. 4), pp. 517-24, 1990/Aug. | Journal Article
 
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.
Clauss, Matthias AGerlach, MGerlach, HBrett, JWang, FFamilletti, P CPan, Y COlander, J VConnolly, D T and Stern, David B
The Journal of experimental medicine, vol. 172, (no. 6), pp. 1535-45, 1990/Dec/1. | Journal Article
1988
The epidermal G1-chalone: an endogenous tissue-specific inhibitor of epidermal cell proliferation.
Richter, K HClauss, MHöfle, WSchnapke, R and Marks, F
Annals of the New York Academy of Sciences, vol. 548, pp. 204-210, 1988. | Journal Article